QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cerence-lowers-fy2026-sales-guidance-from-500000m-to-300000m-320000m-vs-246385m-est

Cerence (NASDAQ:CRNC) lowers FY2026 sales outlook from $500.000 million to $300.000 million-$320.000 million vs $246.385 millio...

 cerence-sees-q1-sales-110000m-120000m-vs-61461m-est

Cerence (NASDAQ:CRNC) sees Q1 sales of $110.000 million-$120.000 million vs $61.461 million analyst estimate.

Core News & Articles

https://storage.courtlistener.com/recap/gov.uscourts.txed.225543/gov.uscourts.txed.225543.219.0.pdf

Core News & Articles

Cerence AI is developing a mobile work AI agent for the car that integrates with Microsoft 365 Copilot, enabling hands-free mob...

 cerence-announces-restructuring-plan-for-foreign-operations-expects-72m-79m-in-charges

On September 2, 2025, Cerence Inc. (the "Company") announced a restructuring plan with respect to certain foreign opera...

Core News & Articles

https://storage.courtlistener.com/recap/gov.uscourts.txwd.1172862962/gov.uscourts.txwd.1172862962.1.0.pdf

Core News & Articles

Cerence Inc. (NASDAQ:CRNC) ("Cerence AI"), a global leader pioneering conversational AI-powered user experiences, today...

 goldman-sachs-maintains-neutral-on-cerence-raises-price-target-to-10

Goldman Sachs analyst Mark Delaney maintains Cerence (NASDAQ:CRNC) with a Neutral and raises the price target from $9 to $10.

 cerence-raises-fy2025-sales-guidance-from-236000m-247000m-to-244000m-249000m-vs-241299m-est

Cerence (NASDAQ:CRNC) raises FY2025 sales outlook from $236.000 million-$247.000 million to $244.000 million-$249.000 million v...

 cerence-sees-q4-sales-53000m-58000m-vs-57454m-est

Cerence (NASDAQ:CRNC) sees Q4 sales of $53.000 million-$58.000 million vs $57.454 million analyst estimate.

 cerence-q3-eps-006-beats-025-estimate-sales-62236m-beat-54942m-estimate

Cerence (NASDAQ:CRNC) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.25) by 76...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION